<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Complement-fixing antibodies to a <z:e sem="disease" ids="C0019340" disease_type="Disease or Syndrome" abbrv="">herpes</z:e>-like virus derived from a <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt tumor</z:e>-cell line developed in each of 21 patients with infectious mononu-cleosis </plain></SENT>
<SENT sid="1" pm="."><plain>These antibodies were absent in <z:hpo ids='HP_0000001'>all</z:hpo> serums before the patients became ill, appeared during the early phases of illness, and persisted for long periods of time </plain></SENT>
<SENT sid="2" pm="."><plain>These antibodies are distinct from heterophile antibodies </plain></SENT>
<SENT sid="3" pm="."><plain>None of the patients developed immune responses to <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e>, cytomegalo-, or reoviruses in the course of their illness </plain></SENT>
<SENT sid="4" pm="."><plain>The data suggest that the development of complement-fixing antibodies to this <z:e sem="disease" ids="C0019340" disease_type="Disease or Syndrome" abbrv="">herpes</z:e>-like virus in these patients may be linked to <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> </plain></SENT>
</text></document>